Study of Jitongning Tablet to Treat Spondyloarthritis

NCT03932019 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

238

Enrollment

INDUSTRY

Sponsor class

Conditions

Spondyloarthritis

Interventions

DRUG: Jitongning tablet(High-dose )
DRUG: Jitongning tablet(Low-dose )
DRUG: Placebo

Sponsor

Tasly Pharmaceutical Group Co., Ltd